BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36479084)

  • 1. Case report: Complex paraneoplastic syndromes in thymoma with nephrotic syndrome, cutaneous amyloidosis, myasthenia gravis, and Morvan's syndrome.
    Liu H; Dong Z; Zhang M; Pang R; Xu J; He P; Mei W; Zhang S; You G; Li W
    Front Oncol; 2022; 12():1002808. PubMed ID: 36479084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report.
    Galié E; Renna R; Plantone D; Pace A; Marino M; Jandolo B; Koudriavtseva T
    Oncol Lett; 2016 Oct; 12(4):2716-2719. PubMed ID: 27698847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma.
    Lee EK; Maselli RA; Ellis WG; Agius MA
    J Neurol Neurosurg Psychiatry; 1998 Dec; 65(6):857-62. PubMed ID: 9854961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy.
    Hor JY; Lim TT; Cheng MC; Chia YK; Wong CK; Lim SM; Cheah CF; Tan K; Easaw PES; Leite MI
    J Neuroimmunol; 2018 Apr; 317():100-102. PubMed ID: 29395322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morvan's Syndrome: The Importance of Knowing Different Risk-Associated Phenotypes and Antibodies in Identifying the Correct Underlying Tumor.
    Ramalho AR; Abreu Fernandes J; Magalhães JT; Rocha MJ; Cunha G; Petrova M; Moura J; Santos L
    Cureus; 2023 Jan; 15(1):e33841. PubMed ID: 36819439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple paraneoplastic diseases occurring in the same patient after thymomectomy.
    Briani C; Cagnin A; Blandamura S; Altavilla G
    J Neurooncol; 2010 Sep; 99(2):287-8. PubMed ID: 20146085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraneoplastic disorders in thymoma patients.
    Evoli A; Lancaster E
    J Thorac Oncol; 2014 Sep; 9(9 Suppl 2):S143-7. PubMed ID: 25396312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A complicated case of metastatic thymoma.
    Mather H
    BMJ Support Palliat Care; 2016 Mar; 6(1):116-8. PubMed ID: 25394917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic syndromes of the neuromuscular junction: therapeutic options in myasthenia gravis, lambert-eaton myasthenic syndrome, and neuromyotonia.
    van Sonderen A; Wirtz PW; Verschuuren JJ; Titulaer MJ
    Curr Treat Options Neurol; 2013 Apr; 15(2):224-39. PubMed ID: 23263888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical case of Morvan's syndrome.
    Lotan I; Djaldetti R; Hellman MA; Benninger F
    J Clin Neurosci; 2016 Mar; 25():132-4. PubMed ID: 26549678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome.
    Rinaldi C; Russo CV; Filla A; De Michele G; Marano E
    Neurol Sci; 2009 Jun; 30(3):237-9. PubMed ID: 19259618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morvan's syndrome: An unusual presentation of a solid pseudopapillary pancreatic tumor.
    Saluja A; Verma J; Anees S; Nangia A; Dhamija RK
    J Neurosci Rural Pract; 2022; 13(4):768-770. PubMed ID: 36743755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isaacs' syndrome as the initial presentation of malignant thymoma and associated with double-positive voltage-gated potassium channel complex antibodies, a case report.
    Li KC; Liao MF; Wu YR; Lyu RK
    BMC Neurol; 2022 Mar; 22(1):74. PubMed ID: 35246046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravenous immunoglobulin therapy in Morvan syndrome secondary to recurrent thymic carcinoma].
    Horta Baas G
    Medwave; 2015 Nov; 15(10):e6323. PubMed ID: 26639057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.
    Gastaldi M; De Rosa A; Maestri M; Zardini E; Scaranzin S; Guida M; Borrelli P; Ferraro OE; Lampasona V; Furlan R; Irani SR; Waters P; Lang B; Vincent A; Marchioni E; Ricciardi R; Franciotta D
    Eur J Neurol; 2019 Jul; 26(7):992-999. PubMed ID: 30714278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morvan Syndrome Manifesting as Autoimmune Paraneoplastic Encephalitis Associated with Thymoma and Antivoltage Gated Potassium Channel (Leucine Rich, Glioma Inactivated 1) Antibody Detected using F 18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Kamaleshwaran KK; Senthilkumar E; Ramkumar E; Ruth R
    Indian J Nucl Med; 2022; 37(2):166-168. PubMed ID: 35982802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
    Irani SR; Alexander S; Waters P; Kleopa KA; Pettingill P; Zuliani L; Peles E; Buckley C; Lang B; Vincent A
    Brain; 2010 Sep; 133(9):2734-48. PubMed ID: 20663977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of paraneoplastic neurological syndrome associated with thymoma].
    Liu HS; Ren HT; Zhou LX; Li SQ; Peng B; Cui LY; Guan HZ
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(35):2770-2774. PubMed ID: 28954337
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome.
    Díaz-Manera J; Rojas-García R; Gallardo E; Juárez C; Martínez-Domeño A; Martínez-Ramírez S; Dalmau J; Blesa R; Illa I
    Nat Clin Pract Neurol; 2007 Jul; 3(7):405-10. PubMed ID: 17611489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoma and Myasthenia Gravis: An Examination of a Paraneoplastic Manifestation.
    Itani M; Goldman Gollan Y; Ezell K; Mohanna M; Sabbagh S; Mears C; Mears KA; Dominguez B; Feinsilber D; Nahleh Z
    Cureus; 2023 Feb; 15(2):e34828. PubMed ID: 36919063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.